Anapneo Therapeutics

Trailblazing Therapy
for Sleep Apnea

A New Approach to Prevent and Treat Sleep Apnea

Anapneo compounds prevent sleep apnea and normalize breathing by inhibiting the mechanism underlying sleep apnea, not just the symptoms.

Cutting Edge Technology

Anapneo compounds inhibit sleep apnea by targeting a novel mechanism of respiratory control.

World-Leading Scientific Expertise

Anapneo scientists are recognized as leaders in the fields of respiratory control and drug development.

Anapneo Therapeutics

Trailblazing Therapy
for Sleep Apnea

A New Approach to Prevent and Treat Sleep Apnea

Anapneo compounds prevent sleep apnea and normalize breathing by inhibiting the mechanism underlying sleep apnea, not just the symptoms.

Cutting Edge Technology

Anapneo compounds inhibit sleep apnea by targeting a novel mechanism of respiratory control.

World-Leading Scientific Expertise

Anapneo scientists are recognized as leaders in the fields of respiratory control and drug development.

Welcome to Anapneo Therapeutics

A New Approach to Prevent and Treat Sleep Apnea

Anapneo Therapeutics is developing new medications for sleep apnea, a serious condition for which no pharmacotherapies are FDA-approved. Snoring, daytime sleepiness, and other short-term effects of sleep apnea are well known. More importantly, patients with untreated or unsuccessfully treated sleep apnea have increased risks of potentially life-threatening long-term effects that include hypertension, heart disease, stroke, and type II diabetes.

The current standard of care for obstructive sleep apnea, CPAP, is not tolerated by many patients. CPAP is also ineffective or only partially effective in other patients, and nearly half of all sleep apnea patients discontinue CPAP use within several months of treatment initiation. Furthermore, CPAP does not treat central sleep apnea. New treatment strategies for sleep apnea are essential.

Anapneo scientists have designed and are developing a new family of compounds to prevent and treat sleep apnea. In studies in preclinical models that recapitulate the human disease, completely non-toxic doses of Anapneo compounds inhibit both obstructive sleep apnea and central sleep apnea. Anapneo compounds maintain normal breathing rhythms through a novel molecular mechanism that addresses the underlying cause of sleep apnea, and not just its symptoms.

CONTACT US HERE

11 + 10 =